Original research
by
Evans, Elizabeth A. et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
Studied outcomes of buprenorphine treatment delivered in jail settings
Findings/Key points
Among incarcerated adults with opioid use disorder, risk of recidivism after jail exit is lower among those who were offered buprenorphine during incarceration. Findings support the growing movement in jails nationwide to offer buprenorphine and other agonist medications for opioid use disorder.
Design/methods
We examined outcomes of all incarcerated adults with opioid use disorder (n = 469) who did (FCSO n = 197) and did not (HCHC n = 272) have the opportunity to receive buprenorphine.
Keywords
Mortality
Harm reduction
Crime
Legal system/law enforcement
Substitution/OAT
